Anti-GCC1 monoclonal antibody

Pre-made anti-GCC1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GCC1/GCC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2523-Ab-1/ GM-Tg-hg-IP2523-Ab-2Anti-Human GCC1 monoclonal antibodyHuman
GM-Tg-rg-IP2523-Ab-1/ GM-Tg-rg-IP2523-Ab-2Anti-Rat GCC1 monoclonal antibodyRat
GM-Tg-mg-IP2523-Ab-1/ GM-Tg-mg-IP2523-Ab-2Anti-Mouse GCC1 monoclonal antibodyMouse
GM-Tg-cynog-IP2523-Ab-1/ GM-Tg-cynog-IP2523-Ab-2Anti-Cynomolgus/ Rhesus macaque GCC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2523-Ab-1/ GM-Tg-felg-IP2523-Ab-2Anti-Feline GCC1 monoclonal antibodyFeline
GM-Tg-cang-IP2523-Ab-1/ GM-Tg-cang-IP2523-Ab-2Anti-Canine GCC1 monoclonal antibodyCanine
GM-Tg-bovg-IP2523-Ab-1/ GM-Tg-bovg-IP2523-Ab-2Anti-Bovine GCC1 monoclonal antibodyBovine
GM-Tg-equg-IP2523-Ab-1/ GM-Tg-equg-IP2523-Ab-2Anti-Equine GCC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2523-Ab-1/ GM-Tg-hg-IP2523-Ab-2; GM-Tg-rg-IP2523-Ab-1/ GM-Tg-rg-IP2523-Ab-2;
GM-Tg-mg-IP2523-Ab-1/ GM-Tg-mg-IP2523-Ab-2; GM-Tg-cynog-IP2523-Ab-1/ GM-Tg-cynog-IP2523-Ab-2;
GM-Tg-felg-IP2523-Ab-1/ GM-Tg-felg-IP2523-Ab-2; GM-Tg-cang-IP2523-Ab-1/ GM-Tg-cang-IP2523-Ab-2;
GM-Tg-bovg-IP2523-Ab-1/ GM-Tg-bovg-IP2523-Ab-2; GM-Tg-equg-IP2523-Ab-1/ GM-Tg-equg-IP2523-Ab-2
Products NameAnti-GCC1 monoclonal antibody
Formatmab
Target NameGCC1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GCC1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2523-Ag-1Recombinant multi-species GCC1/ GCC1P/ GCC88 protein


    Target information

    Target IDGM-IP2523
    Target NameGCC1
    Gene ID79571,74375,100361513,697975,482269,101098616,539985,100056608
    Gene Symbol and Synonyms4932417P04Rik,GCC1,GCC1P,GCC88
    Uniprot AccessionQ96CN9
    Uniprot Entry NameGCC1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000179562
    Target ClassificationN/A

    The target: GCC1, gene name: GCC1, also named as GCC1P, GCC88. The protein encoded by this gene is a peripheral membrane protein. It is sensitive to brefeldin A. This encoded protein contains a GRIP domain which is thought to be used in targeting. It may play a role in the organization of trans-Golgi network subcompartment involved with membrane transport. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.